As Los Angeles County again mandates masking indoors – even for the fully vaccinated – local health officials in the U.S. are closely eyeing their own COVID-19 vaccination and infection rates.
As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.
If Big Pharma wants to achieve the ultimate image makeover, it must capitalize on the current public good will about its COVID-19 vaccines by prioritizing socially responsible practices.
Major companies and business groups are being brought into the rollout effort to speed up the rate of vaccination, opening the way potentially for workplace jabs later in the year.
This treatment would work by targeting the SARS-CoV-2 virus itself and stopping it in its tracks. The evidence we have so far is promising, but it’s still very early days.
Fiona Russell, The University of Melbourne; John Hart, Murdoch Children's Research Institute e Katherine Gibney, The Peter Doherty Institute for Infection and Immunity
The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute